## APPN: Appian Corporation - XLK: Technology

### Executive Summary

VALUE thesis: PEG 0.12 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-5.9% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($34.15)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 9 ($0.00M) |
| Sells | 2 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 13.9% (+13.0%)
- Blackrock Inc.: 8.0% (+6.7%)
- Lead Edge Capital Ma: 4.2% (+11.5%)
- Abdiel Capital Advis: 3.1% (-82.8%)
- Arrowstreet Capital,: 3.0% (+86.9%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-5.9% 5d) with bearish MACD, trend may be turning.
2. Elevated short interest (8.7%): bears positioning against stock.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.12 indicates undervaluation relative to growth. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $2.8B |
| Beta | 0.85 |
| 52W Range | $24.00 - $46.06 |
| Short Interest | 8.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.12 |
| Forward P/E | 49.5 |
| Current P/E | 70.2 |
| YoY Growth | 42.0% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from -3.6% to -9.5% (-5.9% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 13.5pp (needs >4.0% for momentum thesis). AM_20 at -7.5% indicates price below own 20MA trend. Underperforming sector by 10.7pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.21x) but short-term weakness (below SMA20). MACD histogram bearish (-0.53), momentum weakening. RSI neutral at 46.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -9.54% (CS: 1) | Weak |
| RSI_14 | 46.1 | Neutral |
| MACD Histogram | -0.53 | Bearish |
| vs SMA20 | 0.925x | Below |
| vs SMA50 | 1.073x | Above |
| vs SMA200 | 1.209x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $38.07
- **Stop Loss:** $34.15 (10.3% risk)
- **Target:** $45.91 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 352
- **Position Value:** $13,400.64
- **Portfolio %:** 13.40%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-18 (Est: $0.08)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.05 | $0.32 | +490.0% |
| 2025Q2 | $-0.13 | $0.00 | +103.0% |
| 2025Q1 | $0.03 | $0.13 | +315.7% |
| 2024Q4 | $-0.01 | $0.00 | +100.0% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*